Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 809,102 | 654,587 | 390,554 | 507,907 | 648,719 |
| Marketable Securities | 236,121 | 241,055 | 213,694 | 234,257 | 251,761 |
| Receivables | 1,467,793 | 1,439,315 | 1,395,125 | 1,338,462 | 976,372 |
| Inventories | 238,578 | 190,668 | 171,266 | 133,863 | 128,861 |
| Income taxes - deferred | N/A | 60,521 | 69,603 | 62,126 | N/A |
| TOTAL | $2,915,095 | $2,675,640 | $2,283,341 | $2,310,714 | $2,084,759 |
| Non-Current Assets | |||||
| PPE Net | 1,594,120 | 1,475,123 | 1,326,112 | 1,110,597 | 974,309 |
| Investments And Advances | 632,162 | 681,326 | 589,595 | 483,305 | 460,154 |
| Other Non-Current Assets | 467,755 | 350,826 | 327,922 | 293,957 | 318,450 |
| TOTAL | $2,694,037 | $2,507,275 | $2,243,629 | $1,887,859 | $1,752,913 |
| Total Assets | $5,609,132 | $5,182,915 | $4,526,970 | $4,198,573 | $3,837,672 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 644,112 | 577,428 | 529,505 | 462,762 | 483,489 |
| Other current liabilities | 13,563 | 2,506 | 2,291 | 2,185 | 97,146 |
| TOTAL | $811,162 | $734,990 | $601,542 | $536,134 | $654,660 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 153,487 | 155,056 | 69,746 | 71,187 | 74,025 |
| aiOther Non-Current Liabilities | 115,535 | 108,633 | 106,440 | 199,641 | 186,574 |
| TOTAL | $1,143,133 | $1,151,058 | $586,970 | $691,009 | $632,761 |
| Total Liabilities | $1,954,295 | $1,886,048 | $1,188,512 | $1,227,143 | $1,287,421 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 104,788 | 104,065 | 103,688 | 103,278 | 102,617 |
| Common Shares | 108 | 108 | 107 | 105 | 104 |
| Retained earnings | 852,700 | 697,706 | 487,308 | 292,665 | 216,644 |
| Other shareholders' equity | 8,503 | 7,944 | 19,074 | 48,087 | 52,721 |
| TOTAL | $3,654,837 | $3,296,867 | $3,338,458 | $2,971,430 | $2,550,251 |
| Total Liabilities And Equity | $5,609,132 | $5,182,915 | $4,526,970 | $4,198,573 | $3,837,672 |